Clinical trial
Post Marketing Surveillance Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Patients With Relapsing-Remitting Multiple Sclerosis
NCT05366036 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Patients With Relapsing-Remitting Multiple Sclerosis
- Lead sponsor
- Eisai Korea Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 14, 2017
- Completion date
- January 14, 2022
- Enrollment
- 172 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.